Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma

Respiratory Research

Volumn 12, Issue 1, 2011, Pages

  Lundblad, Lennart K A ^a   Rinaldi, Lisa M ^a   Poynter, Matthew E ^a   Riesenfeld, Erik P ^a   Wu, Min ^a   Aimi, Steven ^a   Barone, Leesa M ^b   Bates, Jason H T ^a   Irvin, Charles G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR; METHACHOLINE; OVALBUMIN; POLYLYSINE; SALBUTAMOL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BRONCHODILATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG RECEPTOR BINDING; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF QUANTITATION; LUNG COMPLIANCE; MOUSE; NEBULIZATION; NONHUMAN; RECEPTOR AFFINITY; RESPIRATORY TRACT ALLERGY; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; BREATHING MECHANICS; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; IMMUNOLOGY; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; ISOMERISM; LUNG LAVAGE; METABOLISM; NEBULIZER; PATHOPHYSIOLOGY; TIME;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ALBUTEROL; ANALYSIS OF VARIANCE; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; ISOMERISM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEBULIZERS AND VAPORIZERS; OVALBUMIN; RECEPTORS, ADRENERGIC, BETA; RESPIRATORY MECHANICS; TIME FACTORS;

EID: 79952329522     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-27     Document Type: Article

References (50)

1. Beasley R, Pearce N, Crane J, Burgess C: Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 1999, 104: S18-30.
2. Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI: Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphism. Thorax 2000, 55: 762-767.
3. Erjefalt I, Greiff L, Alkner U, Persson CG: Allergen-induced biphasic plasma exudation responses in guinea pig large airways. Am Rev Respir Dis 1993, 148: 695-701.
4. Greiff L, Wollmer P, Andersson M, Svensson C, Persson CGA: Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax 1998, 53: 1010-1013.
5. Nowak RM, Emerman CL, Schaefer K, Disantostefano RL, Vaickus L, Roach JM: Levalbuterol compared with racemic albuterol in the treatment of acute asthma: results of a pilot study. Am J Emerg Med 2004, 22: 29-36.
6. Keir S, Page C, Spina D: Bronchial hyperresponsiveness induced by chronic treatment with albuterol: Role of sensory nerves. J Allergy Clin Immunol 2002, 110: 388-394.
7. Slattery D, Wong SW, Colin AA: Levalbuterol hydrochloride. Pediatr Pulmonol 2002, 33: 151-157.
8. Penn RB, Frielle T, McCullough JR, Aberg G, Benovic JL: Comparison of R-, S-, and RS-albuterol interaction with human beta 1- and beta 2-adrenergic receptors. Clin Rev Allergy Immunol 1996, 14: 37-45.
9. Waldeck B: Three-dimensional pharmacology, a subject ranging from ignorance to overstatements. Pharmacol Toxicol 2003, 93: 203-210.
10. Waldeck B: Enantiomers of bronchodilating beta2-adrenoceptor agonists: is there a cause for concern? J Allergy Clin Immunol 1999, 103: 742-748.
11. Nowak R: Single-isomer levalbuterol: a review of the acute data. Curr Allergy Asthma Rep 2003, 3: 172-178.
12. Riesenfeld EP, Sullivan MJ, Thompson-Figueroa JA, Haverkamp HC, Lundblad LK, Bates JH, Irvin CG: Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir Res 2010, 11: 22.
13. Lundblad LK, Rinaldi L, Norton RJ, Riesenfeld E, Poynter ME, Barone LM, Irvin CG: Albuterol Isomers Amplify Airway Closure in a Murine Asthma Model. Am J Respir Crit Care Med 2008, 177: A943.
14. Lundblad LKA, Rinaldi L, Norton RJ, Riesenfeld E, Poynter ME, Barone LM, Irvin CG: Albuterol Amplifies Airway Hyperresponsiveness in an Allergic Asthma Model. Am J Respir Crit Care Med 2009, 179: A2414.
15. Lundblad LK, Rinaldi L, Norton RJ, Riesenfeld E, Poynter ME, Barone LM, Irvin CG: Albuterol Isomers Amplify Airway Closure in a Murine Asthma Model. IDEA 2008, 2: 254.
16. Rudmann DG, Moore MW, Tepper JS, Aldrich MC, Pfeiffer JW, Hogenesch H, Tumas DB: Modulation of allergic inflammation in mice deficient in TNF receptors. Am J Physiol Lung Cell Mol Physiol 2000, 279: L1047-1057.
17. Lundblad LKA, Irvin CG, Adler A, Bates JH: A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol 2002, 93: 1198-1207.
18. Lundblad LK, Thompson-Figueroa J, Allen GB, Rinaldi L, Norton RJ, Irvin CG, Bates JH: Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med 2007, 175: 768-774.
19. Schuessler T, Bates J: A computer-controlled research ventilator for small animals: design and evaluation. IEEE Trans Biomed Eng 1995, 42: 860-866.
20. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ: Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992, 72: 168-178.
21. Evans CM, Williams OW, Tuvim MJ, Nigam R, Mixides GP, Blackburn MR, DeMayo FJ, Burns AR, Smith C, Reynolds SD, et al.: Mucin Is Produced by Clara Cells in the Proximal Airways of Antigen-Challenged Mice. Am J Respir Cell Mol Biol 2004, 31: 382-394.
22. Agrawal A, Rengarajan S, Adler KB, Ram A, Ghosh B, Fahim M, Dickey BF: Inhibition of mucin secretion with MARCKS-related peptide improves airway obstruction in a mouse model of asthma. J Appl Physiol 2007, 102: 399-405.
23. Erjefalt, Andersson, Gustafsson, Korsgren, Sonmark, Persson : Allergen challenge-induced extravasation of plasma in mouse airways. Clinical & Experimental Allergy 1998, 28: 1013-1020.
24. Wagers SS, Norton RJ, Rinaldi LM, Bates JHT, Sobel BE, Irvin CG: Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 2004, 114: 104-111.
25. Levitt RC, Mitzner W: Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice. Faseb J 1988, 2: 2605-2608.
26. Duguet A, Biyah K, Minshall E, Gomes R, Wang CG, Taoudi-Benchekroun M, Bates JH, Eidelman DH: Bronchial responsiveness among inbred mouse strains. Role of airway smooth-muscle shortening velocity. Am J Respir Crit Care Med 2000, 161: 839-848.
27. Lofgren JL, Mazan MR, Ingenito EP, Lascola K, Seavey M, Walsh A, Hoffman AM: Restrained whole body plethysmography for measure of strain-specific and allergen-induced airway responsiveness in conscious mice. J Appl Physiol 2006, 101: 1495-1505.
28. Laitinen A, Laitinen LA: Airway morphology: epithelium/basement membrane. Am J Respir Crit Care Med 1994, 150: S14-17.
29. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC: Inflammation of small airways in asthma. J Allergy Clin Immunol 1997, 100: 44-51.
30. Bates JH, Wagers SS, Norton RJ, Rinaldi LM, Irvin CG: Exaggerated airway narrowing in mice treated with intratracheal cationic protein. J Appl Physiol 2006, 100: 500-506.
31. Kalesnikoff J, Galli SJ: New developments in mast cell biology. Nat Immunol 2008, 9: 1215-1223.
32. Bradding P, Walls AF, Holgate ST: The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006, 117: 1277-1284.
33. Anderson SD: How does exercise cause asthma attacks? Curr Opin Allergy Clin Immunol 2006, 6: 37-42.
34. Taylor DR, Sears MR, Herbison GP, Flannery EM, Print CG, Lake DC, Yates DM, Lucas MK, Li Q: Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax 1993, 48: 134-138.
35. Allen GB, Leclair TR, von Reyn J, Larrabee YC, Cloutier ME, Irvin CG, Bates JH: Acid aspiration-induced airways hyperresponsiveness in mice. J Appl Physiol 2009, 107: 1763-1770.
36. Larche M: Regulatory T Cells in Allergy and Asthma. Chest 2007, 132: 1007-1014.
37. Loza MJ, Foster S, Peters SP, Penn RB: Interactive effects of steroids and [beta]-agonists on accumulation of type 2 T cells. Journal of Allergy and Clinical Immunology 2008, 121 (750) : e751-755. e753
38. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK: Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 1995, 25: 200-206.
39. Cho SH, Hartleroad JY, Oh CK: (S)-albuterol increases the production of histamine and IL-4 in mast cells. Int Arch Allergy Immunol 2001, 124: 478-484.
40. Townley R, Horiba M: Airway hyperresponsiveness. Clinical Reviews in Allergy and Immunology 2003, 24: 85-109.
41. Busse WW, Lemanske RF$sf:$esf:: Asthma. N Engl J Med 2001, 344: 350-362.
42. Wagers SS, Haverkamp HC, Bates JH, Norton RJ, Thompson-Figueroa JA, Sullivan MJ, Irvin CG: Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J Appl Physiol 2007, 102: 221-230.
43. Gosens R, Zaagsma J, Meurs H, Halayko A: Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006, 7: 73.
44. Cockcroft DW, Swystun VA: Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax 1997, 52: 845-848.
45. Ramsay CM, Cowan J, Flannery E, McLachlan C, Taylor DR: Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma. Eur J Clin Pharmacol 1999, 55: 353-359.
46. Raissy HH, Harkins M, Esparham A, Kelly HW: Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction. Pharmacotherapy 2007, 27: 1231-1236.
47. Uchida DA, Irvin CG, Ballowe C, Larsen G, Cott GR: Cationic proteins increase the permeability of cultured rabbit tracheal epithelial cells: modification by heparin and extracellular calcium. Exp Lung Res 1996, 22: 85-99.
48. Homma T, Bates JHT, Irvin CG: Airway hyperresponsiveness induced by cationic proteins in vivo: site of action. Am J Physiol Lung Cell Mol Physiol 2005, 289: L413-418.
49. Winter MC, Shasby SS, Ries DR, Shasby DM: PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: protective effect of beta-agonists. Am J Physiol Lung Cell Mol Physiol 2006, 291: L628-635.
50. Bates JH, Cojocaru A, Haverkamp HC, Rinaldi LM, Irvin CG: The synergistic interactions of allergic lung inflammation and intratracheal cationic protein. Am J Respir Crit Care Med 2008, 177: 261-268.